Medtronic introduced Touch Surgery™ Aide, an AI-native surgical computing platform that provides real-time decision support during robotic surgeries, powered by NVIDIA technology. The platform enhances the Touch Surgery™ ecosystem by enabling multimodal AI insights during procedures, improving surgical precision and workflow. Its first FDA-cleared AI application, Instrument Exit Point (IEP), alerts surgeons when instruments move out of view in robotic-assisted surgeries. This innovation marks a significant step towards AI-driven, personalized surgery and is expected to expand into laparoscopic procedures and other surgical specialties in the future.
Medtronic plc, a global healthcare technology leader, announced it will release its financial results for the first quarter of fiscal year 2027 on September 1, 2026. The quarter ends on July 31, 2026. The company will issue a news release with summar...
ResearchAndMarkets.com released a comprehensive report analyzing over 1,230 bioinformatics collaboration and licensing deals from 2019 to 2026. The report offers detailed insights into deal structures, including upfront payments, milestones, royaltie...
